Huraypositive (“Huray”) is a Seoul-based digital health company that builds chronic-disease programs with payers and hospitals, combining connected devices, daily-life coaching, and clinician-backed protocols. Flagship deployments include MyHealthNote (type-2 diabetes care for Samsung Fire & Marine Insurance policyholders) and HiD (kidney-disease self-management developed with the Korean Society of Nephrology). The platform blends app-captured biometrics with digital/human coaching to improve outcomes and reduce claims.

Why They Stand Out

• Payer-integrated distribution: Huray’s programs are embedded with major insurers, e.g., Samsung Fire & Marine’s diabetes service, giving immediate reach, measurable actuarial impact, and a clear ROI narrative.

• Condition depth (diabetes → CKD): Protocols span diet, meds, blood glucose/BP, weight and more, with a CKD app (HiD) co-developed with nephrology experts, useful for multi-morbidity and step-up care.

• Evidence-first posture: The company spotlights clinically verified blood-sugar reduction and maintains a long operating history in diabetes management, an edge in a crowded digital health field.

• Expansion via clinical & R&D partnerships: Recent alliance with Xlife Sciences AG and OncoMASTER tees up precision-medicine/digital-health co-development with an Asian focus.

Why Watch

Two powerful tailwinds are converging in Korea and broader Asia: (1) rising chronic-disease burden (e.g., diabetes prevalence among Korean adults reached ~13.9% by 2020) and (2) CKD urgency (≈4.6M Koreans with CKD and a national plan to cut CKD by 10% by 2033). Payers and health systems are moving from claims processing to outcomes-based prevention, which favors platforms already wired into insurers and clinics. Huray’s payer-led go-to-market, expanding disease coverage, and new precision-health partnerships position it to replicate the Korea playbook in other Asian markets.

Meet the Team

• Doo-Ah Choi — CEO. Founder-operator who has led Huray’s insurer- and hospital-integrated digital programs across diabetes, kidney disease, and adjacent therapeutic areas.

• Ho-Min Park — CTO. Heads platform and data engineering for Huray’s device integrations and coaching stack, translating clinical protocols into scalable software.

WOWS Take

With payer distribution baked in, condition depth across diabetes and CKD, and fresh momentum in precision-health collaborations, Huray reads like a category compounder in Asia’s digital-care layer. Rising prevalence, policy attention, and insurer cost pressure create a durable demand story, Huray’s mix of daily-use engagement plus measurable claims outcomes makes it one of the more investable digital-health platforms emerging from the region.

Want to be part of the digital-health OS wave for Asia’s payers?
Check out Huray’s profile on WOWS Global’s Deal Flow platform and discover other innovative startups.